JONDRIMOR Trademark

Trademark Overview

On Friday, May 11, 2012, a trademark application was filed for JONDRIMOR with the United States Patent and Trademark Office. The USPTO has given the JONDRIMOR trademark a serial number of 79114853. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, May 11, 2022. This trademark is owned by Boehringer Ingelheim International GmbH. The JONDRIMOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
jondrimor

General Information

Serial Number79114853
Word MarkJONDRIMOR
Filing DateFriday, May 11, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, May 11, 2022
Registration Number4277867
Registration DateTuesday, January 22, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 6, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 23, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDE

Trademark Events

Event DateEvent Description
Wednesday, January 4, 2023UNDELIVERABLE MAIL - NO ACTION TAKEN
Sunday, December 4, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, December 4, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, July 3, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, June 4, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, June 4, 2020INVALIDATION PROCESSED
Thursday, April 23, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, August 23, 2019CANCELLED SECTION 71
Monday, October 7, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, September 16, 2013FINAL DISPOSITION NOTICE SENT TO IB
Monday, September 16, 2013FINAL DISPOSITION PROCESSED
Monday, April 22, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 22, 2013REGISTERED-PRINCIPAL REGISTER
Sunday, November 18, 2012NOTIFICATION PROCESSED BY IB
Tuesday, November 6, 2012PUBLISHED FOR OPPOSITION
Wednesday, October 17, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 17, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 17, 2012NOTICE OF PUBLICATION
Tuesday, October 2, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 1, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 27, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 27, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 17, 2012ASSIGNED TO LIE
Sunday, September 9, 2012REFUSAL PROCESSED BY IB
Friday, September 7, 2012PAPER RECEIVED
Tuesday, August 28, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 17, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 17, 2012REFUSAL PROCESSED BY MPU
Friday, August 17, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 16, 2012NON-FINAL ACTION WRITTEN
Wednesday, August 15, 2012NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Wednesday, August 15, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 14, 2012NON-FINAL ACTION WRITTEN
Tuesday, August 14, 2012ASSIGNED TO EXAMINER
Tuesday, July 31, 2012APPLICATION FILING RECEIPT MAILED
Friday, July 27, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 26, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 26, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

jondrimor system pharmaceutical preparations diseases disorders treatment blood nervous peripheral genitourinary